These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 8161982)

  • 61. Patient preference quality of life measures in dermatology.
    McCombs K; Chen SC
    Dermatol Ther; 2007; 20(2):102-9. PubMed ID: 17537138
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Value of the time trade off method for measuring utilities in patients with rheumatoid arthritis.
    Tijhuis GJ; Jansen SJ; Stiggelbout AM; Zwinderman AH; Hazes JM; Vliet Vlieland TP
    Ann Rheum Dis; 2000 Nov; 59(11):892-7. PubMed ID: 11053068
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Interpretation of health and vision utilities in low vision patients.
    Malkin AG; Goldstein JE; Massof RW
    Optom Vis Sci; 2012 Mar; 89(3):288-95. PubMed ID: 22227913
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Utilities measured by rating scale, time trade-off, and standard gamble: review and reference for health care professionals.
    Morimoto T; Fukui T
    J Epidemiol; 2002 Mar; 12(2):160-78. PubMed ID: 12033527
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Health Condition Impacts in a Nationally Representative Cross-Sectional Survey Vary Substantially by Preference-Based Health Index.
    Hanmer J; Cherepanov D; Palta M; Kaplan RM; Feeny D; Fryback DG
    Med Decis Making; 2016 Feb; 36(2):264-74. PubMed ID: 26314728
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Quality-of-life assessment in osteoporosis: health-status and preference-based measures.
    Tosteson AN; Hammond CS
    Pharmacoeconomics; 2002; 20(5):289-303. PubMed ID: 11994039
    [TBL] [Abstract][Full Text] [Related]  

  • 67. From clinically relevant outcome measures to quality of life in epilepsy: A time trade-off study.
    de Kinderen RJ; Wijnen BF; van Breukelen G; Postulart D; Majoie MH; Aldenkamp AP; Evers SM
    Epilepsy Res; 2016 Sep; 125():24-31. PubMed ID: 27344139
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Preference-based quality of life measures in people with visual impairment.
    Kymes SM; Lee BS
    Optom Vis Sci; 2007 Aug; 84(8):809-16. PubMed ID: 17700344
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A new explanation for the difference between time trade-off utilities and standard gamble utilities.
    Bleichrodt H
    Health Econ; 2002 Jul; 11(5):447-56. PubMed ID: 12112493
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Psychometric properties and comparison of four health utility approaches among myopia patients in China.
    Dou L; Xu Y; Chen G; Li S
    Health Qual Life Outcomes; 2023 Jul; 21(1):66. PubMed ID: 37403059
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A clinical trial to evaluate the measurement properties of 2 direct preference instruments administered with and without hypothetical marker states.
    Schünemann HJ; Griffith L; Stubbing D; Goldstein R; Guyatt GH
    Med Decis Making; 2003; 23(2):140-9. PubMed ID: 12693876
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The impact of living with a functional and aesthetic nasal deformity after primary rhinoplasty: a utility outcomes score assessment.
    Sinno H; Izadpanah A; Thibaudeau S; Christodoulou G; Tahiri Y; Slavin SA; Lin SJ
    Ann Plast Surg; 2012 Oct; 69(4):431-4. PubMed ID: 22964667
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Comparison of time-tradeoff utilities and rating scale values of cancer patients and their relatives: evidence for a possible plateau relationship.
    O'Leary JF; Fairclough DL; Jankowski MK; Weeks JC
    Med Decis Making; 1995; 15(2):132-7. PubMed ID: 7783573
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A multi-attribute model of prostate cancer patient's preferences for health states.
    Chapman GB; Elstein AS; Kuzel TM; Nadler RB; Sharifi R; Bennett CL
    Qual Life Res; 1999 May; 8(3):171-80. PubMed ID: 10472149
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Measurement of health state utilities for economic appraisal.
    Torrance GW
    J Health Econ; 1986 Mar; 5(1):1-30. PubMed ID: 10311607
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Relationship between health status and utility measures in older claudicants.
    Bartman BA; Rosen MJ; Bradham DD; Weissman J; Hochberg M; Revicki DA
    Qual Life Res; 1998 Jan; 7(1):67-73. PubMed ID: 9481152
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Psychometric considerations in evaluating health-related quality of life measures.
    Hays RD; Anderson R; Revicki D
    Qual Life Res; 1993 Dec; 2(6):441-9. PubMed ID: 8161978
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Preference-based comparison of quality of life associated with vision loss in Black and White ophthalmic populations in the US.
    Brown GC; Brown MM; Sharma S
    Can J Ophthalmol; 2024 Feb; 59(1):24-30. PubMed ID: 36427536
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Maximal endurable time states and the standard gamble: more preference reversals.
    Stalmeier PF; Verheijen AL
    Eur J Health Econ; 2013 Dec; 14(6):971-7. PubMed ID: 23224226
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Comparison of health state utility values derived using time trade-off, rank and discrete choice data anchored on the full health-dead scale.
    Brazier J; Rowen D; Yang Y; Tsuchiya A
    Eur J Health Econ; 2012 Oct; 13(5):575-87. PubMed ID: 21959651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.